Essential Therapeutics, Inc.
🏢 View company profile →12Patents
0Active
12Granted
31Portfolio score
Filing activity: May 20, 1998 → Dec 30, 2002
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6596723B1 | Fungal efflux pump inhibitors | Chemistry; Metallurgy | 34 | Expired |
| US6436980B1 | Peptidomimetic efflux pump inhibitors | Emerging Cross-Sectional Technologies | 28 | Expired |
| US6689782B2 | Fungal efflux pump inhibitors | Chemistry; Metallurgy | 19 | Expired |
| US6638718B1 | Methods of screening for compounds active on staphylococcus aureus target genes | Chemistry; Metallurgy | 6 | Expired |
| US6630303B1 | Methods of screening for compounds active on Staphylococcus aureus target genes | Chemistry; Metallurgy | 5 | Expired |
| US6551591B1 | Antibiotics from microbispora | Chemistry; Metallurgy | 5 | Expired |
| US6750038B1 | Rapid antibiotic susceptibility test | Chemistry; Metallurgy | 4 | Expired |
| US6599893B2 | Cephalosporin antibiotics and prodrugs thereof | Human Necessities | 1 | Expired |
| US6723716B1 | 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof | Chemistry; Metallurgy | 1 | Expired |
| US6482921B1 | Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6514746B1 | Staphylococcus aureus histidine protein kinase essential genes | Chemistry; Metallurgy | 0 | Expired |
| US6495591B1 | Fungal efflux pump inhibitors | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.